Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.
NCT00034203 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
The purpose of this study is to determine whether a humanized monoclonal antibody (efalizumab) is safe and effective in the treatment of rheumatoid arthritis.
Conditions
Interventions
- DRUG
-
efalizumab
Sponsors & Collaborators
-
XOMA (US) LLC
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-04-30
- Completion
- 2003-08-31
Countries
- United States
Study Locations
More Related Trials
-
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
NCT00837434 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis
NCT00550043 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis
NCT00649545 ·Status: APPROVED_FOR_MARKETING
-
A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy
NCT03001219 ·Status: TERMINATED ·Phase: PHASE2
-
A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis
NCT00380744 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201
NCT00831649 ·Status: TERMINATED ·Phase: PHASE2
-
Phase 2 AMG 714 in Rheumatoid Arthritis
NCT00433875 ·Status: COMPLETED ·Phase: PHASE2
-
A Rheumatoid Arthritis Study in Participants
NCT01202760 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis
NCT05489224 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2/3 Open-label Extension Study to Evaluate Long-Term Safety and Efficacy With VX-509 in Subjects With Rheumatoid Arthritis
NCT01830985 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis
NCT00049751 ·Status: COMPLETED ·Phase: PHASE3
-
A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis
NCT01834807 ·Status: COMPLETED
-
A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid Arthritis
NCT01640548 ·Status: COMPLETED
-
Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis
NCT00504595 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)
NCT00144521 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy
NCT00844714 ·Status: COMPLETED ·Phase: NA
-
Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis
NCT00279760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
NCT00299546 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
NCT01285310 ·Status: TERMINATED ·Phase: PHASE2
-
Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)
NCT02097524 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3462817 in Participants With Rheumatoid Arthritis
NCT04634253 ·Status: COMPLETED ·Phase: PHASE2
-
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
NCT01198002 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).
NCT02222493 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Patients With Rheumatoid Arthritis
NCT00966875 ·Status: COMPLETED ·Phase: PHASE2
-
An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy
NCT00973479 ·Status: COMPLETED ·Phase: PHASE3